Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 23.71% is 54% above its 5-year average of 15.37%, near the high end of its 5-year range (0.00%–26.50%).
As of the fiscal period ended Sunday, May 31, 2026. 1.94% below its 12-month average of 24.18%.
Reported quarterly debt to assets ratio; no daily interpolation. Q4 FY2026 (2026-05-31): 23.71%.
DEBT TO ASSETS RATIO
23.71%
DEBT TO ASSETS RATIO AVG TTM
24.18%
DEBT TO ASSETS RATIO AVG 3Y
21.73%
DEBT TO ASSETS RATIO AVG 5Y
15.37%
DEBT TO ASSETS RATIO AVG 10Y
7.90%
DEBT TO ASSETS RATIO AVG 15Y
0.03%
DEBT TO ASSETS RATIO AVG 20Y
0.02%
CURRENT VS TTM AVG
-1.94%
CURRENT VS 3Y AVG
+9.09%
CURRENT VS 5Y AVG
+54.29%
CURRENT VS 10Y AVG
+200.14%
CURRENT VS 15Y AVG
+74963.63%
CURRENT VS 20Y AVG
+105968.17%
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+26243.23%
vs the sector median at left
Neogen Corporation
Market Cap
$2.61B
Debt to Assets Ratio
23.71%
TTM Avg
24.18%
3Y Avg
21.73%
5Y Avg
15.37%
Market Cap
$2.60B
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.60B
Debt to Assets Ratio
0.18%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.56B
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.66B
Debt to Assets Ratio
0.71%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.70B
Debt to Assets Ratio
0.46%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.71B
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.49B
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Neogen Corporation (NEOG) | $2.61B | 23.71% | 24.18% | 21.73% | 15.37% |
| NewAmsterdam Pharma Company N.V. (NAMS)vs › | $2.60B | 0.00% | N/A | N/A | N/A |
| Beam Therapeutics Inc. (BEAM)vs › | $2.60B | 0.18% | N/A | N/A | N/A |
| Privia Health Group, Inc. (PRVA)vs › | $2.56B | 0.01% | N/A | N/A | N/A |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.66B | 0.71% | N/A | N/A | N/A |
| Precigen, Inc. (PGEN)vs › | $2.69B | 0.58% | N/A | N/A | N/A |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.70B | 0.46% | N/A | N/A | N/A |
| MBX Biosciences, Inc. Common Stock (MBX)vs › | $2.71B | 0.01% | N/A | N/A | N/A |
| Supernus Pharmaceuticals, Inc. (SUPN)vs › | $2.49B | 0.03% | N/A | N/A | N/A |
| AtriCure, Inc. (ATRC)vs › | $2.73B | 0.11% | N/A | N/A | N/A |
Debt/Assets
23.7%
Debt/Equity
0.38
Current Ratio
3.82
Interest Coverage
-0.4x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-05-31 | 23.71% |
| 2026-02-28 | 23.62% |
| 2025-11-30 | 23.60% |
| 2025-08-31 | 23.46% |
| 2025-05-31 | 26.50% |
| 2025-02-28 | 22.13% |
| 2024-11-30 | 22.01% |
| 2024-08-31 | 19.80% |
| 2024-05-31 | 19.77% |
| 2024-02-29 | 19.43% |
| 2023-11-30 | 19.33% |
| 2023-08-31 | 19.49% |
| 2023-05-31 | 19.71% |
| 2023-02-28 | 19.62% |
| 2022-11-30 | 20.25% |
| 2022-08-31 | 0.00% |
| 2022-05-31 | 0.15% |
| 2022-02-28 | 0.00% |
| 2021-11-30 | 0.00% |
| 2021-08-31 | 0.00% |
| 2021-05-31 | 0.14% |
| 2021-02-28 | 0.14% |
| 2020-11-30 | 0.18% |
| 2020-08-31 | 0.22% |
| 2020-05-31 | 0.13% |
| 2020-02-29 | 0.23% |
| 2019-11-30 | 0.27% |
| 2019-08-31 | 0.00% |
| 2019-05-31 | 0.00% |
| 2019-02-28 | 0.00% |
| 2018-11-30 | 0.00% |
| 2018-08-31 | 0.00% |
| 2018-05-31 | 0.00% |
| 2018-02-28 | 0.00% |
| 2017-11-30 | 0.00% |
| 2017-08-31 | 0.00% |
| 2017-05-31 | 0.00% |
| 2017-02-28 | 0.00% |
| 2016-11-30 | 0.00% |
| 2016-08-31 | 0.00% |
| 2016-05-31 | 0.00% |
| 2016-02-29 | 0.00% |
| 2015-11-30 | 0.00% |
| 2015-08-31 | 0.00% |
| 2015-05-31 | 0.00% |
| 2015-02-28 | 0.00% |
| 2014-11-30 | 0.00% |
| 2014-08-31 | 0.00% |
| 2014-05-31 | 0.00% |
| 2014-02-28 | 0.00% |
| 2013-11-30 | 0.00% |
| 2013-08-31 | 0.00% |
| 2013-05-31 | 0.00% |
| 2013-02-28 | 0.00% |
| 2012-11-30 | 0.00% |
| 2012-08-31 | 0.00% |
| 2012-05-31 | 0.00% |
| 2012-02-29 | 0.00% |
| 2011-11-30 | 0.00% |
| 2011-08-31 | 0.00% |
| 2011-05-31 | 0.00% |
| 2011-02-28 | 0.00% |
| 2010-11-30 | 0.00% |
| 2010-08-31 | 0.00% |
| 2010-05-31 | 0.00% |
| 2010-02-28 | 0.00% |
| 2009-11-30 | 0.00% |
| 2009-08-31 | 0.00% |
| 2009-05-31 | 0.00% |
| 2009-02-28 | 0.00% |
| 2008-11-30 | 0.00% |
| 2008-08-31 | 0.00% |
| 2008-05-31 | 0.00% |
| 2008-02-29 | 0.00% |
| 2007-11-30 | 0.00% |
| 2007-08-31 | 0.00% |
| 2007-05-31 | 0.00% |
| 2007-02-28 | 0.00% |
| 2006-11-30 | 0.00% |
| 2006-08-31 | 0.00% |
| 2006-05-31 | 11.28% |
| 2006-02-28 | 14.94% |
| 2005-11-30 | 0.00% |
| 2005-08-31 | 0.00% |
| 2005-05-31 | 0.00% |
| 2005-02-28 | 3.58% |
| 2004-11-30 | 3.89% |
| 2004-08-31 | 3.98% |
| 2004-05-31 | 6.50% |
| 2004-02-29 | 7.89% |
| 2003-11-30 | 5.71% |
| 2003-08-31 | 0.00% |
| 2003-05-31 | 0.00% |
| 2003-02-28 | 0.00% |
| 2002-11-30 | 0.00% |
| 2002-08-31 | 0.00% |
